Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.

Williams, Kerry J; Picus, Joel; Trinkhaus, Kim; Fournier, Chloe C; Suresh, Rama; James, Joan S; Tan, Benjamin R

Williams, Kerry J; Picus, Joel; Trinkhaus, Kim; Fournier, Chloe C; Suresh, Rama; James, Joan S; Tan, Benjamin R.

Affiliation

Williams KJ; Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MI 63110, USA.

HPB (Oxford) ; 12(6): 418-26, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20662793

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biliary Tract Neoplasms/drug therapy; Adenocarcinoma/mortality; Adenocarcinoma/pathology; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Biliary Tract Neoplasms/mortality; Biliary Tract Neoplasms/pathology; Carboplatin/administration & dosage; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Missouri; Survival Rate; Time Factors; Treatment Outcome; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biliary Tract Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: HPB (Oxford) Journal subject: GASTROENTEROLOGIA Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google